Skip to content

Advertisement

  • Erratum
  • Open Access

Erratum to: An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia

  • 1,
  • 2,
  • 2, 3,
  • 4,
  • 2,
  • 5,
  • 5,
  • 6,
  • 7,
  • 7,
  • 7,
  • 8,
  • 9,
  • 1,
  • 1,
  • 10,
  • 2, 3,
  • 2, 3 and
  • 2, 3, 11Email author
BMC Medicine201614:213

https://doi.org/10.1186/s12916-016-0765-5

  • Published:

The original article was published in BMC Medicine 2016 14:171

Erratum

After publication of the original article [1], it came to the authors’ attention that there was an error in the PQ pharmacokinetics sub-section of the Background section. The following sentence is affected:

“There is no PK interaction between PQ and either artesunate-pyronaridine [76] or mefloquine [69, 77]; no PK interaction data exist for PQ and artemether-lumefantrine (AL).”

This sentence should have read as follows:

“AS pyronaridine increased PQ exposure by 15% without affecting significantly cPQ exposure [76]. There is no PK interaction between PQ and mefloquine [69, 77]; no PK interaction data exist for PQ and artemether-lumefantrine (AL).”

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
National Center for Parasitology, Entomology and Malaria Control, Corner St. 92, Trapeng Svay Village, Sangkat Phnom Penh, Thmei, Khan Sen Sok, Phnom Penh, Cambodia
(2)
Mahidol Oxford Tropical Medicine Research Unit (MORU), 420/6 Rajvithi Road, Rajthevee, Bangkok, 10400, Thailand
(3)
Oxford Centre for Tropical Medicine and Global Health, Nuffield Department of Medicine Research Building, University of Oxford, Old Road Campus, Roosevelt Drive, Oxford, OX3 7FZ, UK
(4)
MSF Belgium Cambodia Malaria Program, #19, Street 388, Sangkat Tuol Svay Prey, Khan Chamkarmon, PO Box 1933, Phnom Penh, Cambodia
(5)
University Research Co., LLC, MK Building, House #10 (2nd floor), St. 214, Chey Chumneas, Daun Penh, Phnom Penh, Cambodia
(6)
University Research Co., LLC Washington DC: 7200 Wisconsin Ave, Bethesda, MD 20814, USA
(7)
Institut Pasteur du Cambodge, 5 Monivong Boulevard, PO Box 983, Phnom Penh, 12201, Cambodia
(8)
Malaria Consortium, House #91 Street 95, Boeung Trabek, Chamkar Morn, Phnom Penh, Cambodia
(9)
Laboratory of Malaria and Vector Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rockville, MD 20852, USA
(10)
FHI 360 Cambodia Office, #03, Street 330 Boeung Keng Kang III Khan Chamkamon, PO Box: 2586, Phnom Penh, Cambodia
(11)
Centre de Médecine Humanitaire, Hôpitaux Universitaires de Genève, Genève, Switzerland

References

  1. Leang R, Khu NH, Mukaka M, Debackere M, Tripura R, Kheang ST. An optimised age-based dosing regimen for single low-dose primaquine for blocking malaria transmission in Cambodia. BMC Med. 2016;14:171. doi:10.1186/s12916-016-0701-8.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement